{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:25Z","timestamp":1790095045003,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.vaccine.2021.10.034","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T09:43:31Z","timestamp":1635155011000},"page":"6860-6865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"39","author":[{"given":"Xueting","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3272-5877","authenticated-orcid":false,"given":"Yunli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9420-1211","authenticated-orcid":false,"given":"Haican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.vaccine.2021.10.034_b0005","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.vaccine.2019.06.078","article-title":"Ag85b\/ESAT6-CFP10 adjuvanted with aluminum\/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"issue":"9553","key":"10.1016\/j.vaccine.2021.10.034_b0010","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(06)69863-2","article-title":"Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis","volume":"368","author":"Aziz","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.034_b0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-3083.2007.02064.x","article-title":"Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins","volume":"67","author":"M\u00e5len","year":"2008","journal-title":"Scand J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.10.034_b0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/003591573102401109","article-title":"Preventive Vaccination Against Tuberculosis with BCG","volume":"24","author":"Calmette","year":"1931","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"9","key":"10.1016\/j.vaccine.2021.10.034_b0025","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3201\/eid1009.030921","article-title":"Potential public health impact of new tuberculosis vaccines","volume":"10","author":"Ziv","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.034_b0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/oxfordjournals.bmb.a072277","article-title":"BCG vaccination against tuberculosis and leprosy","volume":"44","author":"Fine","year":"1988","journal-title":"Br Med Bull"},{"issue":"51","key":"10.1016\/j.vaccine.2021.10.034_b0035","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","article-title":"Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX","volume":"29","author":"Niu","year":"2011","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2021.10.034_b0040","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1016\/j.vaccine.2016.08.075","article-title":"Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy","volume":"34","author":"Gupta","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.10.034_b0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.intimp.2017.10.015","article-title":"Immunogenicity and protective efficacy of multistage vaccine candidates (Mtb8.4-HspX and HspX-Mtb8.4) against Mycobacterium tuberculosis infection in mice","volume":"53","author":"Liu","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"9493","key":"10.1016\/j.vaccine.2021.10.034_b0050","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.034_b0055","doi-asserted-by":"crossref","first-page":"e00100","DOI":"10.1128\/CMR.00100-19","article-title":"Tuberculosis Vaccine Development: Progress in Clinical Evaluation","volume":"33","author":"Sable","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2021.10.034_b0060","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1128\/iai.57.8.2481-2488.1989","article-title":"Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis","volume":"57","author":"Andersen","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2021.10.034_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/690328","article-title":"The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection","volume":"2011","author":"Palma","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2021.10.034_b0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1119(96)00242-9","article-title":"A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system","volume":"176","author":"Braibant","year":"1996","journal-title":"Gene"},{"issue":"16","key":"10.1016\/j.vaccine.2021.10.034_b0075","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/0264-410X(95)00084-E","article-title":"Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles","volume":"13","author":"Vordermeier","year":"1995","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2021.10.034_b0080","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1016\/j.vaccine.2018.05.075","article-title":"Intranasal inoculate of influenza virus vaccine against lethal virus challenge","volume":"36","author":"Fan","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.10.034_b0085","doi-asserted-by":"crossref","unstructured":"Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE,et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.Clinical Infectious Diseases 2013; 58(4):470-480. Doi: 10.1093\/cid\/cit790","DOI":"10.1093\/cid\/cit790"},{"issue":"188","key":"10.1016\/j.vaccine.2021.10.034_b0090","first-page":"1","article-title":"Role of Fused Mycobacterium tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines","volume":"5","author":"Junqueira-Kipnis","year":"2014","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.10.034_b0095","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.034_b0100","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1462-5822.2007.00884.x","article-title":"The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice","volume":"9","author":"Palma","year":"2007","journal-title":"Cell Microbiol"},{"issue":"33","key":"10.1016\/j.vaccine.2021.10.034_b0105","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.vaccine.2008.05.050","article-title":"The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response","volume":"26","author":"Palma","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.10.034_b0110","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/IAI.73.3.1898-1902.2005","article-title":"Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence","volume":"73","author":"Peirs","year":"2005","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2021.10.034_b0115","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.158.12.5921","article-title":"Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection","volume":"158","author":"Zhu","year":"1997","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.034_b0120","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.162.2.1113","article-title":"Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors","volume":"162","author":"Tanghe","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.10.034_b0125","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4049\/jimmunol.180.2.683","article-title":"Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses","volume":"180","author":"Kumar","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.034_b0130","doi-asserted-by":"crossref","first-page":"e1000373","DOI":"10.1371\/journal.ppat.1000373","article-title":"Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques","volume":"5","author":"Stahl-Hennig","year":"2009","journal-title":"PLoS Pathog"},{"issue":"S1","key":"10.1016\/j.vaccine.2021.10.034_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-14-S1-S13","article-title":"Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis","volume":"14","author":"Borrero","year":"2013","journal-title":"BMC Immunology"},{"key":"10.1016\/j.vaccine.2021.10.034_b0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2018.04.004","article-title":"Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis","volume":"53","author":"Achkar","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.10.034_b0145","first-page":"89","article-title":"Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo","volume":"77","author":"Nordly","year":"2011","journal-title":"Eur J Pharm Biopharmofficial journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik"},{"issue":"9","key":"10.1016\/j.vaccine.2021.10.034_b0150","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/eji.201243124","article-title":"MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant","volume":"43","author":"Orr","year":"2013","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.10.034_b0155","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2021.10.034_b0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molimm.2019.10.023","article-title":"Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC)","volume":"117","author":"Lew","year":"2020","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.10.034_b0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"38","key":"10.1016\/j.vaccine.2021.10.034_b0170","doi-asserted-by":"crossref","first-page":"E5636","DOI":"10.1073\/pnas.1611987113","article-title":"CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection","volume":"113","author":"Foreman","year":"2016","journal-title":"PNAS"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:03:36Z","timestamp":1759403016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21013542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0264410X21013542"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}